Skip to main content

Table 6 Traditional meta-analysis results of optimal transplantation timing

From: The optimal transplantation strategy of umbilical cord mesenchymal stem cells in spinal cord injury: a systematic review and network meta-analysis based on animal studies

Group

Transplantation timing

The third week (SMD)

The fifth week (SMD)

High dose + local transplantation

Acute phase

2.62 (0.31, 4.94)

3.59 (1.99, 7.20)

Subacute phase

3.29 (2.11, 4.77)

5.41 (3.48, 7.33)

Low dose + local transplantation

Acute phase

2.22 (1.23, 3.22)

2.83 (1.56, 4.11)

Subacute phase

2.49 (0.48, 3.51)

4.33 (2.53, 6.13)

High dose + intravenous transplantation

Acute phase

1.57 (0.90, 3.03)

1.63 (0.83, 3.43)

Subacute phase

2.51 (0.81, 3.22)

2.93 (2.11, 3.75)